The mechanism of dead-in-bed syndrome and other sudden unexplained nocturnal deaths

Current Diabetes Reviews

Volumn 5, Issue 4, 2009, Pages 210-215

  Parekh, B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Arousal; Glucose; Hypoglycaemia; Orexin; Sleep apnoea; Sudden death

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARNITINE; MEMBRANE PROTEIN; OREXIN A; PROTEIN SLC22A4; PROTEIN SLC22A5; UNCLASSIFIED DRUG;

ADAPTATION; AUTONOMIC DYSFUNCTION; CARDIOPULMONARY INSUFFICIENCY; DEAD IN BED SYNDROME; FATTY ACID METABOLISM; GENE MUTATION; GENETIC ASSOCIATION; HEART ARRHYTHMIA; HUMAN; HYPOGLYCEMIA; HYPOXIA; INSULIN DEPENDENT DIABETES MELLITUS; MUSCLE HYPOTONIA; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SUDDEN DEATH; SYMPATHETIC TONE; SYNDROME; THEORY; THORAX PRESSURE;

CIRCADIAN RHYTHM; DEATH, SUDDEN; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; SLEEP APNEA SYNDROMES;

EID: 70450191682     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339909789804387     Document Type: Review

References (90)

1. Start RD, Barber C, Kaschula RO, Robinson RT. The 'dead in bed syndrome'- a cause of sudden death in Type 1 diabetes mellitus. Histopathology 2007; 51(6): 843-845 (Pubitemid 350179396)
2. Sovik O, Thordarson H. Dead-in-bed syndrome in young diabetic patients. Diabetes Care 1999; 22(Suppl 2): B40-2. (Pubitemid 29107147)
3. Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med 1991; 8(1): 49-58.
4. Tu E, Twigg SM, Duflou J, Semsarian C. Causes of death in young Australians with type 1 diabetes: a review of coronial postmortem examinations. Med J Aust 2008; 188(12): 699-702.
5. Thordarson H, Søvik O. Dead in bed syndrome in young diabetic patients in Norway. Diabet Med 1995; 12(9): 782-787
6. Koltin D, Daneman D. 'Dead-in-bed' syndrome - a diabetes nightmare. Pediatr Diabetes 2008; 9(5): 504-507
7. David SHB. 'Dead in bed syndrome - a hypothesis'. Diabet Obes Metab 2006; 8 (3): 261-263
8. Heller SR. Abnormalities of the electrocardiogram during hypoglycaemia: the cause of the dead in bed syndrome? Int J Clin Pract Suppl 2002; 129: 27-32.
9. Robinson RT, Harris ND, Ireland RH, et al. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes 2003; 52(6): 1469-1474
10. Weston PJ, Gill GV. Is undetected autonomic dysfunction responsible for sudden death in Type 1 diabetes mellitus? The 'dead in bed' syndrome revisited. Diabet Med 1999; 16(8): 626-631
11. Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005; 54(12): 3592-3601
12. Ramsli HM, Therkelsen SP, Søvik O, Thordarson H. Unexpected and unexplained deaths among young patients with diabetes mellitus. Tidsskr Nor Laegeforen 2004; 124(23): 3064-3065 (Pubitemid 40310943)
13. Forsyth L, Scott HM, Howatson A, et al. Genetic variation in hepatic glucose-6-phosphatase system genes in cases of sudden infant death syndrome. J Pathol 2007; 212(1): 112-120 (Pubitemid 46746296)
14. Cox JN, Guelpa G, Terrapon M. Islet-cell hyperplasia and sudden infant death. Lancet 1976; 2(7988): 739-740
15. Léger-Ravet MB, Bouillie C, Sempoux C, Rahier J, Faucher JN. Pancreatic adenomatous hyperplasia and sudden infant death. Ann Pathol 1997; 17(3): 206-208
16. Boles RG, Buck EA, Blitzer MG, et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. J Pediatr 1998; 132(6): 924-933
17. Lee RS, Lam CW, Lai CK, et al. Carnitine-acylcarnitine translocase deficiency in three neonates presenting with rapid deterioration and cardiac arrest. Hong Kong Med J 2007; 13(1): 66-68
18. Bonnet D, Martin D, Pascale De Lonlay, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation 1999; 100(22): 2248-2253
19. Stanley CA. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency. Adv Pediatr 1987; 34: 59-88.
20. Chalmers RA, Stanley CA, English N, Wigglesworth JS. Mitochondrial carnitineacylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr 1997; 131(2): 220-225
21. Howat AJ, Bennett MJ, Variend S, Shaw L. Deficiency of medium chain fatty acylcoenzyme A dehydrogenase presenting as the sudden infant death syndrome. Br Med J 1984; 288(6422): 976. (Pubitemid 14115356)
22. Arnon SS, Mills DC, Day PA, et al. Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis. J Pediatr 1984; 104(1): 34-40.
23. Sharief N, Khan K, Conlan P. Overwhelming sepsis presenting as sudden unexpected death. Arch Dis Child 1993; 69(3): 381-383 (Pubitemid 23291328)
24. Highet AR. An infectious aetiology of sudden infant death syndrome. J Appl Microbiol 2008; 105(3): 625-635
25. Miller SI, Wallace RJ, Jr, Musher DM, Septimus EJ, Kohl S, Baughn RE. Hypoglycemia as a manifestation of sepsis. Am J Med 1980; 68(5): 649-654
26. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352(12): 1206-1214
27. Bradley TD, Floras JS. Sleep apnea and heart failure: Part I: obstructive sleep apnoea. Circulation 2003; 107(12): 1671-1678 (Pubitemid 36397338)
28. Remmers JE, deGroot WJ, Sauerland EK, Anch AM. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978; 44: 931-938
29. McNicholas WT, Fitzgerald MX. Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J 1984; 289(6449): 878. (Pubitemid 14006113)
30. Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008; 168(3): 297-301. (Pubitemid 351281676)
31. Dematteis M, Julien C, Guillermet C, et al. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 2008; 177(2): 227-235
32. Wang DW, Desai RR, Crotti L, et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 2007; 115(3): 368-376 (Pubitemid 46148511)
33. Jackson HA, Accili EA. Evolutionary analyses of KCNQ1 and HERG voltage-gated potassium channel sequences reveal location-specific susceptibility and augmented chemical severities of arrhythmogenic mutations. BMC Evol Biol 2008; 8: 188.
34. Van Norstrand DW, Tester DJ, Ackerman MJ. Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African- American sudden infant death syndrome. Heart Rhythm 2008; 5(5): 712-715
35. Melegh B, Bene J, Mogyorósy G, et al. Phenotypic manifestations of the OCTN2 V295X mutation: sudden infant death and carnitine-responsive cardiomyopathy in Roman families. Am J Med Genet 2004; 131(2): 121-126 (Pubitemid 39578342)
36. Goh KT, Chao TC, Heng BH, Koo CC, Poh SC. Epidemiology of sudden unexpected death syndrome among Thai migrant workers in Singapore. Int J Epidemiol 1993; 22(1): 88-95.
37. Tanchaiswad W. Is sudden unexplained nocturnal death a breathing disorder? Psychiatry Clin Neurosci 1995; 49(2): 111-114
38. Iafolla AK, Browning IB, Roe CR. Familial infantile apnea and immature beta oxidation. Pediatr Pulmonol 1995; 20(3): 167-171
39. Aynsley-Green A, Polak JM, Keeling J, Gough MH, Baum JD. Averted sudden neonatal death due to pancreatic nesidioblastosis. Lancet 1978; 1(8063): 550-551
40. Giunti S, Bruno G, Lillaz E, et al. EURODIAB IDDM Complications Study Group. Incidence and risk factors of prolonged QTc interval in type 1 diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2007; 30(8): 2057-2063
41. Murphy NP, Ford-Adams ME, Ong KK, et al. Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes. Diabetologia 2004; 47(11): 1940-1947
42. Lee S, Harris ND, Robinson RT, et al. Effects of adrenaline and potassium on QTc interval and QT dispersion in man. Eur J Clin Invest 2003; 33(2): 93-98 (Pubitemid 36250077)
43. Ohzeki T, Tamura A, Hanaki K, et al. Long QT syndrome with insulin-dependent diabetes mellitus: contiguous gene syndrome on chromosome 11p. J Intern Med 1993; 234(2): 227-229 (Pubitemid 23244420)
44. Lo SS, Sutton MS, Leslie RD. Information on type 1 diabetes mellitus and QT interval from identical twins. Am J Cardiol 1993; 72(3): 305-309 (Pubitemid 23226309)
45. Peterson LR, Herrero P, McGill J, et al. Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes. Diabetes 2008; 57(1): 32-40.
46. Caprio S, Amiel S, Tamborlane WV, Gelfand RA, Sherwin RS. Defective free-fatty acid and oxidative glucose metabolism in IDDM during hypoglycemia. Influence of glycemic control. Diabetes 1990; 39(2): 134-141
47. Mathur A, Sims HF, Gopalakrishnan D, et al. Molecular heterogeneity in very-longchain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. Circulation 1999; 99(10): 1337-1343 (Pubitemid 29129919)
48. Allison F, Bennett MJ, Variend S, Engel PC. Acylcoenzyme A dehydrogenase deficiency in heart tissue from infants who died unexpectedly with fatty change in the liver. Br Med J 1988; 296(6614): 11-12 (Pubitemid 18025275)
49. Baumgartner D, Scholl-Bürgi S, Sass JO, et al. Prolonged QTc intervals and decreased left ventricular contractility in patients with propionic acidemia. J Pediatr 2007; 150(2): 192-197 (Pubitemid 46127561)
50. Famularo G, De Simone C. A new era for carnitine? Immunol Today 1995; 16(5): 211-213
51. Lanza-Jacoby S, Feagins K, Bodine R, Reibel DK. Impaired carnitine transport in the rat heart during E. coli sepsis. Circ Shock 1991; 35(3): 159-163
52. Nogueira AC, Kawabata V, Biselli P, et al. Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability. Shock 2008; 29(3): 342-348 (Pubitemid 351271705)
53. Mingrone G. Carnitine in type 2 diabetes. Ann NY Acad Sci 2004; 1033: 99-107.
54. Santiago JL, Martínez A, de la Calle H, et al. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study. BMC Med Genet 2006; 7: 54. (Pubitemid 44110896)
55. Paranjape SA, Vavaiya KK, Kale AY, Briski KP. Habituation of insulin-induced hypoglycaemic transcription activation of lateral hypothalamic orexin-A-containing neurons to recurring exposure. Regul Pept 2006; 135(1-2): 1-6. (Pubitemid 43816093)
56. Kuwajima M, Fujihara H, Sei H, et al. Reduced carnitine level causes death from hypoglycemia: possible involvement of suppression of hypothalamic orexin expression during weaning period. Endocr J 2007; 54(6): 911-925 (Pubitemid 351346774)
57. Peever JH, Lai YY, Siegel JM. Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 2003; 89(5): 2591-2600
58. Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999; 96(19): 10911-10916 (Pubitemid 29442243)
59. Yoshida G, Li MX, Horiuchi M, et al. Fasting-induced reduction in locomotor activity and reduced response of orexin neurons in carnitine- deficient mice. Neurosci Res 2006; 55(1): 78-86.
60. Igarashi N, Tatsumi K, Nakamura A, et al. Plasma orexin-A levels in obstructive sleep apnea-hypopnea syndrome. Chest 2003; 124(4): 1381-1385 (Pubitemid 37290048)
61. Matsumura T, Nakayama M, Nomura A, et al. Age-related changes in plasma orexin-A concentrations. Exp Gerontol 2002; 37(8-9): 1127-1130
62. Beckwith JB. Defining the Sudden Infant Death Syndrome. Arch Pediatr Adolesc Med 2003; 157(3): 286-290 (Pubitemid 36343384)
63. Blackwell CC, Moscovis SM, Gordon AE, et al. Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors. J Leukoc Biol 2005; 78(6): 1242-1254 (Pubitemid 41779230)
64. Blackwell CC, Weir DM. The role of infection in sudden infant death syndrome. FEMS Immunol Med Microbiol 1999; 25(1-2): 1-6. (Pubitemid 29317550)
65. Sayers NM, Drucker DB, Telford DR, Morris JA. Effects of nicotine on bacterial toxins associated with cot death. Arch Dis Child 1995; 73(6): 549-551
66. Guilleminault C, Peraita R, Souquet M, Dement WC. Apneas during sleep in infants: possible relationship with sudden infant death syndrome. Science 1990; 4215: 677-679
67. Guilleminault C, Souquet M, Ariagno RL, Korobkin R, Simmons FB. Five cases of near-miss sudden infant death syndrome and development of obstructive sleep apnea syndrome. Pediatrics 1984; 73(1): 71-78 (Pubitemid 14221951)
68. Sawaguchi T, Franco P, Groswasser J, Kahn A. Partial arousal deficiency in SIDS victims and noradrenergic neuronal plasticity. Early Hum Dev 2003; 75: S61-4. (Pubitemid 39658662)
69. Kato I, Franco P, Groswasser J, et al. Incomplete arousal processes in infants who were victims of sudden death. Am J Respir Crit Care Med 2003; 168(11): 1298-1303 (Pubitemid 37487322)
70. Schneider J, Mitchell I, Singhal N, Kirk V, Hasan SU. Prenatal Cigarette Smoke Exposure Attenuates Recovery from Hypoxemic Challenge in Preterm Infants. Am J Respir Crit Care Med 2008; 178(5): 520-526
71. Horne RS, Osborne A, Vitkovic J, et al. Arousal from sleep in infants is impaired following an infection. Early Hum Dev 2002; 66(2): 89-100. (Pubitemid 34168486)
72. Corwin MJ, Lester BM, Sepkoski C, et al. Newborn acoustic cry characteristics of infants subsequently dying of sudden infant death syndrome. Pediatrics1995; 96(1 Pt (1): 73-77
73. Goodkin F. Hypothalamic implications of crib death. 1978; 2(8097): 997.
74. Miller MJ, Kiatchoosakun P. Relationship between respiratory control and feeding in the developing infant. Semin Neonatol 2004; 9(3): 221-227 (Pubitemid 38525026)
75. nd ed. Sudden death in infancy, childhood, and adolescence. Cambridge: Cambridge University Press 2000; p. 523.
76. Park SM, Gaykema RP, Goehler LE. How does immune challenge inhibit ingestion of palatable food? Evidence that systemic lipopolysaccharide treatment modulates key nodal points of feeding neurocircuitry. Brain Behav Immun 2008; 22(8): 1160-1172
77. Kane JK, Parker SL, Li MD. Hypothalamic orexin-A binding sites are downregulated by chronic nicotine treatment in the rat. Neurosci Lett 2001; 298(1): 1-4.
78. Al Madani O, Gordon AE, Weir DM, et al. Pyrogenic toxins of Staphylococcus aureus in sudden unexpected nocturnal deaths in adults and older children: factors influencing the control of inflammatory responses to toxic shock syndrome toxins. FEMS Immunol Med Microbiol 1999; 25(1-2): 207-219 (Pubitemid 29317575)
79. Taheri S, Mahmoodi M, Opacka-Juffry J, Ghatei MA, Bloom SR. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett 1999; 457(1): 157-161 (Pubitemid 29387430)
80. Mitchell EA, Stewart AW. Gender and the sudden infant death syndrome. New Zealand Cot Death Study Group. Acta Paediatr 1997; 86(8): 854-856 (Pubitemid 27342731)
81. Cornwell AC. Sex differences in the maturation of sleep/wake patterns in high risk for SIDS infants. Neuropediatrics 1993; 24(1): 8-14.
82. Watanabe K, Inokuma K, Negoro T. REM sleep prevents sudden infant death syndrome. Eur J Pediatr 1983; 140(4): 289-292
83. Vertes RP, Perry GW. Sudden infant death syndrome: a theory. Neurosci Biobehav Rev 1993; 17(3): 305-312 (Pubitemid 23306318)
84. Kamimura J, Yoshinaga M, Kono Y, et al. A simple method for evaluating abnormal lengthening of the QT interval during the face immersion test. Pediatr Cardiol 2002; 23(2): 122-126 (Pubitemid 36927886)
85. Bonnet D, de Lonlay P, Gautier I, et al. Efficiency of metabolic screening in childhood cardiomyopathies. Eur Heart J 1998; 19(5): 790-793 (Pubitemid 28227164)
86. Han LS, Ye J, Qiu WJ, et al. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four-year report. J Inherit Metab Dis 2007; 30(4): 507-514 (Pubitemid 47377045)
87. Deadwyler SA, Porrino L, Siegel JM, Hampson RE. Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J Neurosci 2007; 27(52): 14239-14247
88. Villain E, Denjoy I, Lupoglazoff JM, et al. Low incidence of cardiac events with betablocking therapy in children with long QT syndrome. Eur Heart J 2004; 25:1405-1411 (Pubitemid 39078249)
89. Hobbs JB, Peterson DR, MossAJ, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006; 296: 1249-1254 (Pubitemid 44394896)
90. Lamhonwah AM, Olpin SE, Pollitt RJ, et al. Novel OCTN2 mutations: no genotypephenotype correlations: early carnitine therapy prevents cardiomyopathy. Am J Med Genet 2002; 111(3): 271-284